Brief: Ipsen And Sutro Biopharma Announce Licensing Agreement For Drug Targeting Solid Tumors

Sutro Biopharma

02/04/2024 06:10

April 2 (Reuters) - Ipsen SA  IPN.PA :
    * IPSEN SA AND SUTRO BIOPHARMA ANNOUNCE EXCLUSIVE GLOBAL
LICENSING
AGREEMENT FOR AN ADC TARGETING SOLID TUMORS
    * IPSEN WILL ASSUME RESPONSIBILITY FOR PHASE I PREPARATION
ACTIVITIES, INCLUDING SUBMISSION OF INVESTIGATIONAL NEW DRUG
(IND) APPLICATION
    * SUTRO BIOPHARMA IS ELIGIBLE TO RECEIVE UP TO $900M IN
POTENTIAL
UPFRONT, DEVELOPMENT, REGULATORY AND COMMERCIAL MILESTONE
PAYMENTS

Source text for Eikon:  urn:newsml:reuters.com:*:nGNX1R41PF
Further company coverage:  IPN.PA 

 (Gdansk Newsroom)
 ((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))